(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.62%) $83.24
(0.17%) $1.760
(0.36%) $2 406.70
(1.29%) $28.75
(-1.17%) $943.30
(-0.14%) $0.938
(-0.28%) $11.01
(0.55%) $0.808
(-0.96%) $93.00
@ $4.14
Issued: 14 Feb 2024 @ 09:30
Return: 23.43%
Previous signal: Feb 12 - 14:00
Previous signal:
Return: -5.91 %
Live Chart Being Loaded With Signals
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs...
Stats | |
---|---|
Today's Volume | 2.44M |
Average Volume | 2.30M |
Market Cap | 294.02M |
EPS | $0 ( 2024-02-07 ) |
Next earnings date | ( $0.0500 ) 2024-05-01 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 127.75 |
ATR14 | $0.00700 (0.14%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-04 | Williams Timothy | Sell | 8 147 | Common Stock |
2024-03-05 | Williams Timothy | Sell | 8 941 | Common Stock |
2024-03-04 | Wijkstrom Joakim | Sell | 7 498 | Common Stock |
2024-03-05 | Wijkstrom Joakim | Sell | 9 229 | Common Stock |
2024-03-04 | Polymeropoulos Mihael Hristos | Sell | 30 884 | Common Stock |
INSIDER POWER |
---|
66.62 |
Last 99 transactions |
Buy: 3 050 635 | Sell: 650 292 |
Volume Correlation
Vanda Pharmaceuticals Inc Correlation
10 Most Positive Correlations | |
---|---|
GOSS | 0.944 |
THTX | 0.944 |
PTPI | 0.938 |
VORB | 0.931 |
TRVN | 0.929 |
LQDT | 0.929 |
TIVC | 0.928 |
XFOR | 0.927 |
SIGA | 0.925 |
CREG | 0.922 |
10 Most Negative Correlations | |
---|---|
RXDX | -0.952 |
AUPH | -0.951 |
POWL | -0.932 |
EZGO | -0.932 |
AVAC | -0.93 |
SUMR | -0.929 |
ALXN | -0.924 |
EMLD | -0.921 |
TCMD | -0.92 |
AVEO | -0.919 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Vanda Pharmaceuticals Inc Correlation - Currency/Commodity
Vanda Pharmaceuticals Inc Financials
Annual | 2023 |
Revenue: | $192.64M |
Gross Profit: | $175.75M (91.23 %) |
EPS: | $0.0437 |
Q4 | 2023 |
Revenue: | $45.27M |
Gross Profit: | $41.81M (92.36 %) |
EPS: | $-0.0417 |
Q3 | 2023 |
Revenue: | $38.82M |
Gross Profit: | $35.75M (92.11 %) |
EPS: | $0.00240 |
Q2 | 2023 |
Revenue: | $46.06M |
Gross Profit: | $42.56M (92.40 %) |
EPS: | $0.0265 |
Financial Reports:
No articles found.
Vanda Pharmaceuticals Inc
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under development include HETLIOZ (tasimelteon) for the treatment of jet lag disorder, smith-magenis syndrome, pediatric Non-24, autism spectrum, and delayed sleep phase disorder; Fanapt (iloperidone) for the treatment of bipolar disorder and a long acting injectable formulation program for the treatment of schizophrenia; and Tradipitant (VLY-686), a small molecule neurokinin-1 receptor (NK-1R) antagonist, for the treatment of atopic dermatitis, gastroparesis, and motion sickness. The company's products under development also comprise VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for various oncology indications; VQW-765, a small molecule nicotinic acetylcholine receptor partial agonist for the treatment of psychiatric disorders; a portfolio of cystic fibrosis transmembrane conductance regulator activators and inhibitors for the treatment of dry eye and ocular inflammation, as well as BPO-27 for the treatment of secretory diarrhea disorders, including cholera; and VHX-896, the active metabolite of iloperidone. It markets its products in the United States, Europe, and Israel. Vanda Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in Washington, the District of Columbia.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators